120 related articles for article (PubMed ID: 11765036)
1. Some structural changes on triazolyl-benzotriazoles and triazolyl-benzimidazolones as potential potassium channel activators. III.
Biagi G; Calderone V; Giorgi I; Livi O; Scartoni V; Baragatti B; Martinotti E
Farmaco; 2001 Nov; 56(11):841-9. PubMed ID: 11765036
[TBL] [Abstract][Full Text] [Related]
2. Triazolyl-benzimidazolones and triazolyl-benzotriazoles: new potential potassium channel activators. II.
Baragatti B; Biagi G; Calderone V; Giorgi I; Livi O; Martinotti E; Scartoni V
Eur J Med Chem; 2000 Oct; 35(10):949-55. PubMed ID: 11121621
[TBL] [Abstract][Full Text] [Related]
3. New 5-substituted-1-(2-hydroxybenzoyl)-benzotriazoles, potassium channel activators. IV.
Biagi G; Giorgi I; Livi O; Scartoni V; Barili PL; Calderone V; Martinotti E
Farmaco; 2001 Nov; 56(11):827-34. PubMed ID: 11765034
[TBL] [Abstract][Full Text] [Related]
4. 5-(4'-Substituted-2'-nitroanilino)-1,2,3-triazoles as new potential potassium channel activators. I.
Biagi G; Calderone V; Giorgi I; Livi O; Scartoni V; Baragatti B; Martinotti E
Eur J Med Chem; 2000; 35(7-8):715-20. PubMed ID: 10960187
[TBL] [Abstract][Full Text] [Related]
5. Benzoyl and/or benzyl substituted 1,2,3-triazoles as potassium channel activators. VIII.
Calderone V; Giorgi I; Livi O; Martinotti E; Mantuano E; Martelli A; Nardi A
Eur J Med Chem; 2005 Jun; 40(6):521-8. PubMed ID: 15922836
[TBL] [Abstract][Full Text] [Related]
6. Structural modifications of benzanilide derivatives, effective potassium channel openers. X.
Calderone V; Coi A; Fiamingo FL; Giorgi I; Leonardi M; Livi O; Martelli A; Martinotti E
Eur J Med Chem; 2006 Dec; 41(12):1421-9. PubMed ID: 17030483
[TBL] [Abstract][Full Text] [Related]
7. 1,4- and 2,4-substituted-1,2,3-triazoles as potential potassium channel activators. VII.
Calderone V; Giorgi I; Livi O; Martinotti E; Martelli A; Nardi A
Farmaco; 2005 May; 60(5):367-75. PubMed ID: 15910810
[TBL] [Abstract][Full Text] [Related]
8. New amido derivatives as potential BKCa potassium channel activators. XI.
Calderone V; Fiamingo FL; Amato G; Giorgi I; Livi O; Martelli A; Martinotti E
Eur J Med Chem; 2008 Apr; 43(4):792-9. PubMed ID: 17692999
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological activity of novel substituted benzanilides as potassium channel activators. V.
Biagi G; Giorgi I; Livi O; Nardi A; Calderone V; Martelli A; Martinotti E; LeRoy Salerni O
Eur J Med Chem; 2004 Jun; 39(6):491-8. PubMed ID: 15183907
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and vasorelaxant activity of 4-(cyclic amido)-2H-naphtho[1,2-b]pyrans.
Chiou WF; Li SY; Ho LK; Hsien ML; Don MJ
Eur J Med Chem; 2002 Jan; 37(1):69-75. PubMed ID: 11841876
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and vasodilatory activity of some thiazolo-triazole derivative.
Demirayak S; Zitouni G; Chevallet P; Erol K; Kiliç FS
Farmaco; 1993 May; 48(5):707-12. PubMed ID: 8343214
[TBL] [Abstract][Full Text] [Related]
12. Functional contribution of the endothelial component to the vasorelaxing effect of resveratrol and NS 1619, activators of the large-conductance calcium-activated potassium channels.
Calderone V; Martelli A; Testai L; Martinotti E; Breschi MC
Naunyn Schmiedebergs Arch Pharmacol; 2007 Mar; 375(1):73-80. PubMed ID: 17203288
[TBL] [Abstract][Full Text] [Related]
13. 1,5-Diarylsubstituted 1,2,3-triazoles as potassium channel activators. VI.
Biagi G; Calderone V; Giorgi I; Livi O; Martinotti E; Martelli A; Nardi A
Farmaco; 2004 May; 59(5):397-404. PubMed ID: 15120319
[TBL] [Abstract][Full Text] [Related]
14. Activation of large-conductance calcium-activated potassium channels by puerarin: the underlying mechanism of puerarin-mediated vasodilation.
Sun XH; Ding JP; Li H; Pan N; Gan L; Yang XL; Xu HB
J Pharmacol Exp Ther; 2007 Oct; 323(1):391-7. PubMed ID: 17652634
[TBL] [Abstract][Full Text] [Related]
15. Vasorelaxant effects of Cerebralcare Granule® are mediated by NO/cGMP pathway, potassium channel opening and calcium channel blockade in isolated rat thoracic aorta.
Qu Z; Zhang J; Gao W; Chen H; Guo H; Wang T; Li H; Liu C
J Ethnopharmacol; 2014 Aug; 155(1):572-9. PubMed ID: 24924524
[TBL] [Abstract][Full Text] [Related]
16. 1,4-Benzothiazine ATP-sensitive potassium channel openers: modifications at the C-2 and C-6 positions.
Martelli A; Manfroni G; Sabbatini P; Barreca ML; Testai L; Novelli M; Sabatini S; Massari S; Tabarrini O; Masiello P; Calderone V; Cecchetti V
J Med Chem; 2013 Jun; 56(11):4718-28. PubMed ID: 23662847
[TBL] [Abstract][Full Text] [Related]
17. 4,6-Disubstituted 2,2-dimethylchromans structurally related to the K(ATP) channel opener cromakalim: design, synthesis, and effect on insulin release and vascular tone.
Sebille S; de Tullio P; Becker B; Antoine MH; Boverie S; Pirotte B; Lebrun P
J Med Chem; 2005 Jan; 48(2):614-21. PubMed ID: 15658874
[TBL] [Abstract][Full Text] [Related]
18. Novel potassium channel activators. III. Synthesis and pharmacological evaluation of 3,4-dihydro-2H-1,4-benzoxazine derivatives: modification at the 2 position.
Matsumoto Y; Uchida A; Nakahara H; Yanagisawa I; Shibanuma T; Nohira H
Chem Pharm Bull (Tokyo); 2000 Mar; 48(3):428-32. PubMed ID: 10726871
[TBL] [Abstract][Full Text] [Related]
19. Effect on K(ATP) channel activation properties and tissue selectivity of the nature of the substituent in the 7- and the 3-position of 4H-1,2,4-benzothiadiazine 1,1-dioxides.
Boverie S; Antoine MH; Somers F; Becker B; Sebille S; Ouedraogo R; Counerotte S; Pirotte B; Lebrun P; de Tullio P
J Med Chem; 2005 May; 48(10):3492-503. PubMed ID: 15887958
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, biological evaluation and structure-activity relationships of new phthalazinedione derivatives with vasorelaxant activity.
Munín J; Quezada E; Cuiñas A; Campos-Toimil M; Uriarte E; Santana L; Viña D
Eur J Med Chem; 2014 Jul; 82():407-17. PubMed ID: 24929291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
